​Realbio Technology Receives Strategic Investment from Zhangjiang Haocheng VC

According to VCBeat, Realbio Technology ("RBT"), a leading company focusing on the human microbiome, has received a strategic majority investment from Shanghai Zhangjiang Haocheng VC Co., Ltd. ("Zhangjiang Haocheng VC"), an investment platform of Shanghai Zhangjiang High-tech Development Co., Ltd. ("Zhangjiang High-tech"). Lucion Venture Capital ("Lucion Capital") also increased the investment in RBT as an existing shareholder. The joint investment will help RBT to realize the national construction and future listing plan.

Dr. Qin Nan, the founder of RBT, said proceeds of this financing would be mainly used to further market the core products -- "COLOWELL^®" for early colorectal cancer screening, and "RealPathogen^TM" for pathogenic microorganism detection based on high-throughput sequencing technology, and apply for the certification of its PCR products. 

RBT, established in 2014 in Shanghai, is a leading high-tech start-up in China that specializes in gene technologies and health services. Headquatered in Shanghai, RBT has set up branches in Hangzhou, Qingdao, Guiyang and other places. RBT has collaborated with top research institutions at home and abroad. So far, the group has received the approval of 40 software copyrights and a dozen patents and published a series of research articles in top journals.

In October 2016, RBT has raised 40 million yuan (US$5.9 million) in a Series Pre-A round, which was invested by Green Pine Capital Partners and Bioclub. In December 2018, the company has completed A+ round of financing with an amount of nearly 100 million yuan led by Lucion Capital, followed by Wuxi Capital and Yuanyi Capital. 

Zhangjiang High-tech was listed on the Shanghai Stock Exchange in April 1996. As an investment platform of Zhangjiang High-tech, Zhangjiang Haocheng VC focuses on projects of biomedical and medical devices, integrated circuits, information technology, intelligent manufacturing and other key scientific and technological fields in Zhangjiang Park in the early, growth and pre-listing stage.

Lucion Capital is an influential professional venture capital institute and the first listed venture capital company in China. The company mainly invests in advanced manufacturing, modern agriculture, marine economy and other advantageous fields in Shandong, China, and other emerging industries including information technology, energy conservation & environmental protection, new energy, new materials, biotechnology and high-end equipment manufacturing.